Akdis M, Aab A, Altunbulakli C, Azkur K, Costa RA, Crameri R, Duan S, Eiwegger T, Eljaszewicz A, Ferstl R, Frei R (2016). Interleukins (from IL-1 to IL-38), interferons, transforming growth factor beta, and TNF-alpha: Receptors, functions, and roles in diseases. J. Allergy Clin. Immunol. 138(4):984-1010.
Crossref

Cloeckaert A, Baucheron S, Vizcaino N, Zygmunt MS (2001). Use of recombinant BP26 protein in serological diagnosis of Brucella melitensis infection in sheep. Clin. Diagn. Lab. Immunol. 8(4):772-775.
Crossref

Costa S, Almeida A, Castro A, Domingues L (2014). Fusion tags for protein solubility, purification and immunogenicity in Escherichia coli: the novel Fh8 system. Front. Microbiol. 5:63.
Crossref

Devos R, Plaetinck G, Cheroutre H, Simons G, Degrave W, Tavernier J, Remaut E, Fiers W (1983). Molecular cloning of human interleukin 2 cDNA and its expression in E. coli. Nucleic Acids Res. 11(13):4307-4323.
Crossref

El-Mowafy M, Bahgat MM, Bilitewski U (2013). Deletion of the HAMP domains from the histidine kinase CaNik1p of Candida albicans or treatment with fungicides activates the MAP kinase Hog1p in S. cerevisiae transformants. BMC Microbiol. 13:209.
Crossref

Garcia-Tunon I, Ricote M, Ruiz A, Fraile B, Paniagua R, Royuela M (2004). Interleukin-2 and its receptor complex (alpha, beta and gamma chains) in in situ and infiltrative human breast cancer: an immunohistochemical comparative study. Breast Cancer Res. 6(1):R1-7.
Crossref

Gatti-Lafranconi P, Natalello A, Ami D, Doglia SM, Lotti M (2011). Concepts and tools to exploit the potential of bacterial inclusion bodies in protein science and biotechnology. FEBS J. 278(14):2408-2418.
Crossref

Gehman LO, Robb RJ (1984). An ELISA-based assay for quantitation of human interleukin 2. J. Immunol. Methods 74(1):39-47.
Crossref

Janik JE, Sharfman WH, Smitht JW, Longo DL, Sznol M, Urba WJ, Figlin R, Pierce WC, Bukowski RM, Fyfe G, Belldegrun A (1993). Erythropoietin production. A potential marker for interleukin-2/interferon-responsive tumors. Cancer 72(9):2656-2659.
Crossref

Ju G, Collins L, Kaffka KL, Tsien WH, Chizzonite R, Crowl R, Bhatt R, Kilian PL (1987). Structure-function analysis of human interleukin-2. Identification of amino acid residues required for biological activity. J. Biol. Chem. 262(12):5723-5731.

Laemmli UK (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227(5259):680-685.
Crossref

Lee MS, Hseu YC, Lai GH, Chang WT, Chen HJ, Huang CH, Lee MS, Wang MY, Kao JY, You BJ, Lin WH (2011). High yield expression in a recombinant E. coli of a codon optimized chicken anemia virus capsid protein VP1 useful for vaccine development. Microb. Cell Fact. 10:56.
Crossref

Lin WC, Yasumura S, Suminami Y, Sung MW, Nagashima S, Stanson J, Whiteside TL (1995). Constitutive production of IL-2 by human carcinoma cells, expression of IL-2 receptor, and tumor cell growth. J. Immunol. 155(10):4805-4816.

Ma X, Zheng W, Wei D, Ma Y, Wang T, Wang J, Liu Q, Yang S (2006). Construction, expression, and purification of HIV-TAT-survivin (T34A) mutant: a pro-apoptosis protein in Escherichia coli. Protein Expr. Purif. 47(1):36-44.
Crossref

Palmer I, Wingfield PT (2004). Preparation and extraction of insoluble (inclusion-body) proteins from Escherichia coli. Current protocols in protein science, Chapter 6: Unit 63.

Reichert TE, Watkins S, Stanson J, Johnson JT, Whiteside TL (1998). Endogenous IL-2 in cancer cells: a marker of cellular proliferation. J. Histochem. Cytochem. 46(5):603-611.
Crossref

Ridings J, Macardle PJ, Byard RW, Skinner J, Zola H (1995). Cytokine receptor expression by solid tumours. Ther. Immunol. 2(2):67-76.

Robb RJ, Kutny RM, Chowdhry V (1983). Purification and partial sequence analysis of human T-cell growth factor. Proc. Natl. Acad. Sci. USA, 80(19):5990-5994.
Crossref

Roediger B, Kyle R, Tay SS, Mitchell AJ, Bolton HA, Guy TV, Tan SY, Forbes-Blom E, Tong PL, Köller Y, Shklovskaya E (2015). IL-2 is a critical regulator of group 2 innate lymphoid cell function during pulmonary inflammation. J. Allergy Clin. Immunol. 136(6):1653-1663.
Crossref

Rosano GL, Ceccarelli EA (2014). Recombinant protein expression in Escherichia coli: advances and challenges. Front. Microbiol. 5:172.
Crossref

Rosenberg SA, Grimm EA, Mcgrogan M, Doyle M, Kawasaki E, Koths K, Mark DF (1984). Biological activity of recombinant human interleukin-2 produced in Escherichia coli. Science 223(4643):1412-1414.
Crossref

Royuela M, De Miguel MP, Bethencourt FR, Fraile B, Arenas MI, Paniagua R (2000). IL-2, its receptors, and bcl-2 and bax genes in normal, hyperplastic and carcinomatous human prostates: immunohistochemical comparative analysis. Growth Factors 18(2):135-146.
Crossref

Schoner RG, Ellis LF, Schoner BE (1992). Isolation and purification of protein granules from Escherichia coli cells overproducing bovine growth hormone. 1985. Biotechnology (Reading, Mass.) 24:349-352.

Sengupta P, Meena K, Mukherjee R, Jain SK, Maithal K (2008). Optimized conditions for high-level expression and purification of recombinant human interleukin-2 in E. coli. Indian J. Biochem. Biophys. 45(2):91-97.

Shaaban MI, Abdelmegeed E, Ali YM (2015). Cloning, Expression, and Purification of Recombinant Uricase Enzyme from Pseudomonas aeruginosa Ps43 Using Escherichia coli. J. Microbiol. Biotechnol. 25(6):887-892.
Crossref

Singh A, Upadhyay V, Upadhyay AK, Singh SM, Panda AK (2015). Protein recovery from inclusion bodies of Escherichia coli using mild solubilization process. Microb. Cell Fact. 14:41.
Crossref

Smith GE, Ju G, Ericson BL, Moschera J, Lahm HW, Chizzonite R, Summers MD (1985). Modification and secretion of human interleukin 2 produced in insect cells by a baculovirus expression vector. Proc. Natl. Acad. Sci. USA. 82(24):8404-8408.
Crossref

Sorensen HP, Mortensen KK (2005a). Soluble expression of recombinant proteins in the cytoplasm of Escherichia coli. Microb. Cell Fact. 4(1):1.
Crossref

Sorensen HP, Mortensen KK (2005b). Advanced genetic strategies for recombinant protein expression in Escherichia coli. J. Biotechnol. 115(2):113-128.
Crossref

Stern AS, Pan YC, Urdal DL, Mochizuki DY, Dechiara S, Blacher R, Wideman J, Gillis S (1984). Purification to homogeneity and partial characterization of interleukin 2 from a human T-cell leukemia. Proc. Natl. Acad. Sci. USA. 81(3):871-875.
Crossref

Taniguchi T, Matsui H, Fujita T, Takaoka C, Kashima N, Yoshimoto R, Hamuro J (1983). Structure and expression of a cloned cDNA for human interleukin-2. Nature 302(5906):305-310.
Crossref

Uma M, Rao PP, Nagalekshmi K, Hegde NR (2016). Expression and purification of polioviral proteins in E. coli, and production of antisera as reagents for immunological assays. Protein Expr. Purif. 128:115-122.
Crossref

Wang X, Liu X, Zhang Y, Wang Z, Zhu G, Han G, Chen G, Hou C, Wang T, Ma N, Shen B (2016). Interleukin (IL)-39 [IL-23p19/Epstein-Barr virus-induced 3 (Ebi3)] induces differentiation/expansion of neutrophils in lupus-prone mice. Clin. Exp. Immunol. 186(2):144-156.
Crossref